Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease

Clinical Gastroenterology and Hepatology - Tập 17 Số 1 - Trang 156-163.e2 - 2019
Mohammad Shadab Siddiqui1, Raj Vuppalanchi1, Mark L. Van Natta2, Erin Hallinan2, Kris V. Kowdley3, Manal F. Abdelmalek4, Brent A. Neuschwander‐Tetri5, Rohit Loomba6, Srinivasan Dasarathy7, Danielle Brandman8, Edward Doo9, James Tonascia2, David E. Kleiner10, Naga Chalasani11, Arun J. Sanyal1
1Division of Gastroenterology & Hepatology, Virginia Commonwealth University, Richmond, Virginia
2Department of Epidemiology, The Johns Hopkins University School of Public Health, Baltimore, Maryland
3Division of Gastroenterology & Hepatology, Swedish Medical Center, Seattle, Washington
4Division of Gastroenterology & Hepatology, Duke University, Durham, North Carolina
5Division of Gastroenterology & Hepatology, Saint Louis University, St Louis, Missouri
6Division of Gastroenterology & Hepatology, University of California San Diego, San Diego, California
7Division of Gastroenterology & Hepatology, Cleveland Clinic Foundation, Cleveland, Ohio
8Division of Gastroenterology & Hepatology, University of California at San Francisco, San Francisco, California
9Liver Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
10National Cancer Institute, Bethesda, Maryland;
11Division of Gastroenterology & Hepatology, Indiana University School of Medicine, Indianapolis, Indiana

Tóm tắt

Từ khóa


Tài liệu tham khảo

Younossi, 2011, Changes in the prevalence of the most common causes of chronic liver diseases in the united states from 1988 to 2008, Clin Gastroenterol Hepatol, 9, 524, 10.1016/j.cgh.2011.03.020

Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701

Ekstedt, 2006, Long-term follow-up of patients with NAFLD and elevated liver enzymes, Hepatology, 44, 865, 10.1002/hep.21327

Rockey, 2009, Liver biopsy, Hepatology, 49, 1017, 10.1002/hep.22742

Ratziu, 2005, Sampling variability of liver biopsy in nonalcoholic fatty liver disease, Gastroenterology, 128, 1898, 10.1053/j.gastro.2005.03.084

Siddiqui, 2016, Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease, Liver Int, 36, 572, 10.1111/liv.13054

Cui, 2015, Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study, Aliment Pharmacol Ther, 41, 1271, 10.1111/apt.13196

2015, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis, J Hepatol, 63, 237, 10.1016/j.jhep.2015.04.006

Wong, 2010, Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease, Hepatology, 51, 454, 10.1002/hep.23312

Ledinghen, 2016, Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease, J Gastroenterol Hepatol, 31, 848, 10.1111/jgh.13219

Castera, 2010, Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations, Hepatology, 51, 828

Wong, 2012, Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease, Am J Gastroenterol, 107, 1862, 10.1038/ajg.2012.331

Vuppalanchi, 2018, Performance characteristics of vibration-controlled transient elastography for evaluation of non-alcoholic fatty liver disease, Hepatology, 67, 134, 10.1002/hep.29489

Park, 2017, Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease, Gastroenterology, 152, 598, 10.1053/j.gastro.2016.10.026

Tapper, 2016, The performance of vibration controlled transient elastography in a US cohort of patients with nonalcoholic fatty liver disease, Am J Gastroenterol, 111, 677, 10.1038/ajg.2016.49

Collins, 2015, Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement, Ann Intern Med, 162, 55, 10.7326/M14-0697

Angulo, 2015, Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease, Gastroenterology, 149, 389, 10.1053/j.gastro.2015.04.043

de Franchis, 2015, Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension, J Hepatol, 63, 743, 10.1016/j.jhep.2015.05.022

Boursier, 2016, Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease, J Hepatol, 65, 570, 10.1016/j.jhep.2016.04.023

Petta, 2015, The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease, Hepatology, 62, 1101, 10.1002/hep.27844

Caldwell, 2009, NASH and cryptogenic cirrhosis: a histological analysis, Ann Hepatol, 8, 346, 10.1016/S1665-2681(19)31748-X

Kim, 2012, Discordance between liver biopsy and fibroscan(R) in assessing liver fibrosis in chronic hepatitis B: risk factors and influence of necroinflammation, PLoS One, 7, e32233, 10.1371/journal.pone.0032233

Lim, 2011, Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B, Hepatogastroenterology, 58, 539

Thông tin
Thông tin xuất bản

Clinical Gastroenterology and Hepatology

Tập 17 Số 1

156-163.e2

Thông tin tác giả